
SI-BONE Inc (SIBN) Stock Forecast & Price Target
SI-BONE Inc (SIBN) Analyst Ratings
Bulls say
SI-BONE Inc. has demonstrated strong financial performance, with a notable gross margin increase of approximately 80 basis points year-over-year, reaching 79.8% in the second quarter of 2025. Revenue growth was significant, up around 23% year-over-year to $46.4 million, reflecting strong demand for its proprietary surgical implant systems. Additionally, the company experienced a 25% year-over-year increase in the number of surgeons utilizing its products, indicating robust market traction and effective sales efforts.
Bears say
SI-BONE Inc. faces significant challenges due to persistent pricing and procedural headwinds within the global spine market, which have resulted in growth slowing to the low-single digits. Additionally, if payors opt to reimburse for competitive products, SI-BONE's market share in the sacroiliac joint fusion market may decline, further impacting the company's revenue potential. Overall, expectations indicate that these unfavorable conditions are likely to persist, casting doubt on the company's ability to achieve sustainable growth.
This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.
SI-BONE Inc (SIBN) Analyst Forecast & Price Prediction
Start investing in SI-BONE Inc (SIBN)
Order type
Buy in
Order amount
Est. shares
0 shares